Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
27.14 EUR
-0.77%
Updated:
Apr 24, 2024
Bayer AG
Selling, General & Administrative
Last
Value
3-Years CAGR
5-Years CAGR
|
Bayer AG
Selling, General & Administrative Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Selling, General & Administrative
-€14.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Selling, General & Administrative
-$63.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Selling, General & Administrative
-€5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Selling, General & Administrative
-€987.3k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Selling, General & Administrative
-€418.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Selling, General & Administrative
-€44.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Selling, General & Administrative?
Selling, General & Administrative
-14.9B
EUR
-14.9B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Selling, General & Administrative amounts to -14.9B EUR.
What is Bayer AG's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-2%
-2%
Over the last year, the Selling, General & Administrative growth was 12%. The average annual Selling, General & Administrative growth rates for Bayer AG have been 2% over the past three years , and -2% over the past ten years .
You don't have any saved screeners yet
